Rituxan for Granulomatosis with Polyangiitis User Reviews
- Ted...
- Taken for 2 to 5 years
- October 22, 2021
"Keeps my disease in check without any severe side effects."
See also:
Monjuvi
Monjuvi is used for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) or follicular ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Breyanzi
Breyanzi is a CAR T cell therapy for large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle ...
Kymriah
Kymriah is used to treat B-cell precursor acute lymphoblastic leukemia (ALL), large B-cell ...
Polivy
Polivy (polatuzumab vedotin-piiq) is a targeted treatment that may be used to treat diffuse large ...
Yescarta
Yescarta is used to treat large B-cell lymphoma and follicular lymphoma (FL) in adults. It is a p ...
Zynlonta
Zynlonta (loncastuximab tesirine) is used to treat relapsed or refractory diffuse large B-cell ...
Xpovio
Xpovio is used to treat multiple myeloma (MM) or relapsed/refractory diffuse large B-cell lymphoma ...
Tazverik
Tazverik (tazemetostat) used for the treatment of patients with epithelioid sarcoma and follicular ...
Are you taking this medicine?
Your review helps others make informed decisions.Learn more about Granulomatosis with Polyangiitis
Care guides
Symptoms and treatments
More about Rituxan (rituximab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (53)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
- En español
"I’ve been receiving Rituxan infusions for granulomatosis with polyangiitis (GPA) for almost four years. Induction started with one infusion per week for four weeks. Six months later, I was given two more infusions, two weeks apart. I was then switched to one maintenance infusion every six months. Labs showed that I was in remission after infusion #7. Currently, I receive one maintenance infusion every six months. I have had no side effects from Rituxan, and have not had a relapse of the GPA."